English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, March 23, 2022
Alset International Limited establishes Alset Mining Pte. Ltd. to embark on cryptocurrency mining activities
Monday, February 21, 2022
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
Monday, October 5, 2020
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
Friday, September 18, 2020
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Friday, July 31, 2020
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development
Wednesday, June 24, 2020
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
Wednesday, June 17, 2020
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
Monday, June 1, 2020
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Friday, April 24, 2020
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
Wednesday, March 18, 2020
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575